Efficacy of different treatment modalities for acute and chronic phases of the febrile infection-related epilepsy syndrome: A systematic review. (July 2020)
- Record Type:
- Journal Article
- Title:
- Efficacy of different treatment modalities for acute and chronic phases of the febrile infection-related epilepsy syndrome: A systematic review. (July 2020)
- Main Title:
- Efficacy of different treatment modalities for acute and chronic phases of the febrile infection-related epilepsy syndrome: A systematic review
- Authors:
- Kessi, Miriam
Liu, Fangyun
Zhan, Yalan
Tang, Yulin
Wu, Liwen
Yang, Lifen
Zhang, Ci-Liu
Yin, Fei
Peng, Jing - Abstract:
- Highlights: 12.2% of the cases with febrile infection-related epilepsy syndrome (FIRES) die. 11.4% have autoantibodies, and the most common are anti-glutamate. The ketogenic diet is a potential treatment modality in the acute phase. Deaths occur because of the progress of the disease rather than complications of the drugs. Abstract: Background: Febrile infection-related epilepsy syndrome is associated with high mortality and morbidity rates. No systematic review of demographics, aetiologies, good treatment options, and causes of deaths has been performed. Thus, we aimed to focus on these factors to provide a structure for patient management and research. Methods: A deep literature search was performed in PubMed and Embase of all years until May 2019. Results: We retrieved 45 aSrticles: 3 multicentre cohort studies, 13 single-centre cohorts, 1 case series, and 28 case reports. We identified 229 cases: most were from Asia; 53% were males; 11.4% had several types of antibodies, and the most common was anti-glutamate receptor epsilon 2; 30% (69 cases) had good treatment outcomes; 12.2% died; and 56% remained with drug-resistant epilepsies. Univariate analysis revealed a statistically significant association between positive outcomes in Japan and China, the use of the ketogenic diet either acutely or chronically, and the use of steroids acutely or chronically. Taiwan showed a statistically significant association with negative outcomes. Multivariate logistic regression revealedHighlights: 12.2% of the cases with febrile infection-related epilepsy syndrome (FIRES) die. 11.4% have autoantibodies, and the most common are anti-glutamate. The ketogenic diet is a potential treatment modality in the acute phase. Deaths occur because of the progress of the disease rather than complications of the drugs. Abstract: Background: Febrile infection-related epilepsy syndrome is associated with high mortality and morbidity rates. No systematic review of demographics, aetiologies, good treatment options, and causes of deaths has been performed. Thus, we aimed to focus on these factors to provide a structure for patient management and research. Methods: A deep literature search was performed in PubMed and Embase of all years until May 2019. Results: We retrieved 45 aSrticles: 3 multicentre cohort studies, 13 single-centre cohorts, 1 case series, and 28 case reports. We identified 229 cases: most were from Asia; 53% were males; 11.4% had several types of antibodies, and the most common was anti-glutamate receptor epsilon 2; 30% (69 cases) had good treatment outcomes; 12.2% died; and 56% remained with drug-resistant epilepsies. Univariate analysis revealed a statistically significant association between positive outcomes in Japan and China, the use of the ketogenic diet either acutely or chronically, and the use of steroids acutely or chronically. Taiwan showed a statistically significant association with negative outcomes. Multivariate logistic regression revealed the utilisation of the ketogenic diet in the acute phases (P = 0.008, OR = 3.613) and being in Japan (P = 0.003, OR = 3.146) as independent determinants of positive outcomes. Most of the deaths occurred because of the progress of the disease rather than complications of the drugs. Conclusions: Asians are more affected and several cases have antibodies. Positive outcomes are associated with being in Japan and the utilisation of the ketogenic diet in the acute phase. … (more)
- Is Part Of:
- Seizure. Volume 79(2020)
- Journal:
- Seizure
- Issue:
- Volume 79(2020)
- Issue Display:
- Volume 79, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 79
- Issue:
- 2020
- Issue Sort Value:
- 2020-0079-2020-0000
- Page Start:
- 61
- Page End:
- 68
- Publication Date:
- 2020-07
- Subjects:
- Demographics -- aetiologies -- treatment -- sacute phase -- chronic phase -- ketogenic diet -- steroids -- febrile infection-related epilepsy syndrome
Epilepsy -- Periodicals
Epilepsy -- Periodicals
Seizures -- Periodicals
Épilepsie -- Périodiques
Electronic journals
Electronic journals
616.853 - Journal URLs:
- http://www.seizure-journal.com/ ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/13550306 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/10591311 ↗
http://www.sciencedirect.com/science/journal/10591311 ↗
http://www.elsevier.com/journals ↗
http://www.harcourt-international.com/journals/seiz/ ↗ - DOI:
- 10.1016/j.seizure.2020.04.015 ↗
- Languages:
- English
- ISSNs:
- 1059-1311
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8229.100000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 13392.xml